Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate.

Lambrecht LJ, Shekh-Ahmad T, Todd WM, Halvorsen MB, Bialer M.

Epilepsia. 2011 Oct;52(10):1877-83. doi: 10.1111/j.1528-1167.2011.03183.x. Epub 2011 Jul 19.

2.

Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.

Bialer M, Shekh-Ahmad T, Braun TL, Halvorsen MB.

Epilepsia. 2013 Aug;54(8):1444-52. doi: 10.1111/epi.12225. Epub 2013 May 20.

3.

Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.

Nunes T, Sicard E, Almeida L, Falcão A, Rocha JF, Brunet JS, Lefebvre M, Soares-da-Silva P.

Curr Med Res Opin. 2010 Jun;26(6):1355-62. doi: 10.1185/03007991003740861.

PMID:
20377319
4.

Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers.

Clark AM, Kriel RL, Leppik IE, Marino SE, Mishra U, Brundage RC, Cloyd JC.

Epilepsia. 2013 Jun;54(6):1099-105. doi: 10.1111/epi.12134. Epub 2013 Mar 18.

5.

USL255 extended-release topiramate: dose-proportional pharmacokinetics and tolerability in healthy volunteers.

Clark AM, Halvorsen MB, Braun TL, Johnson KM, Cloyd JC.

Epilepsia. 2014 Jul;55(7):1069-76. doi: 10.1111/epi.12654. Epub 2014 May 23.

6.

A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.

Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L.

Clin Ther. 2009 Sep;31(9):2002-11. doi: 10.1016/j.clinthera.2009.09.016.

PMID:
19843490
7.

The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate.

Gidal BE, Clark AM, Anders B, Gilliam F.

Epilepsy Res. 2017 Jan;129:26-32. doi: 10.1016/j.eplepsyres.2016.10.020. Epub 2016 Nov 9.

8.
9.

Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations.

Brittain ST, Wheless JW.

Epilepsy Behav. 2015 Nov;52(Pt A):31-6. doi: 10.1016/j.yebeh.2015.08.029. Epub 2015 Sep 24.

10.

Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.

Jenner P, Könen-Bergmann M, Schepers C, Haertter S.

Clin Ther. 2009 Nov;31(11):2698-711. doi: 10.1016/j.clinthera.2009.10.018.

PMID:
20110012
12.
13.

Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers.

Piñeyro-López A, Piñeyro-Garza E, Gómez-Silva M, Reyes-Araiza R, Flores-Diego MA, Borrego-Alvarado S, Gamino-Peña ME, Vargas-Zapata R, Salazar-Leal ME.

Clin Ther. 2009 Feb;31(2):411-7. doi: 10.1016/j.clinthera.2009.02.001.

PMID:
19302913
14.
16.

Relative bioavailability study with two oral formulations of topiramate using a validated UPLC-MS/MS method.

Saavedra I, Tamayo E, Gamboa A, Sasso J, Varela N, Moreno I, Marchant D, Cáceres D, Quiñones L.

Int J Clin Pharmacol Ther. 2010 May;48(5):342-8.

PMID:
20420791
18.

Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine.

Britzi M, Perucca E, Soback S, Levy RH, Fattore C, Crema F, Gatti G, Doose DR, Maryanoff BE, Bialer M.

Epilepsia. 2005 Mar;46(3):378-84.

19.

Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase.

Shank RP, Doose DR, Streeter AJ, Bialer M.

Epilepsy Res. 2005 Feb;63(2-3):103-12.

PMID:
15715969
20.

Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food.

Kim TE, Kim JR, Jung JA, Kim MJ, Lee SY, Ko JW, Jung WT, Choi YW, Lee HJ, Kim SH, Huh W.

J Clin Pharm Ther. 2014 Apr;39(2):192-5. doi: 10.1111/jcpt.12117. Epub 2013 Dec 11.

PMID:
24325365

Supplemental Content

Support Center